Hanada, K. and Kobayashi, K. 2026. Invariant natural killer T cell–based immunotherapy using alpha-galactosylceramide–pulsed CD14+ monocytes for advanced gallbladder cancer. European Journal of Case Reports in Internal Medicine. 13, 8 (Jul. 2026). DOI:https://doi.org/10.12890/2026_007198.